US Patent Issued to Cytiva Bioprocess R&D on Feb. 17 for "Method for separation of antibodies or antibody fragments being devoid of an Fc region capable of binding to protein A" (Swedish Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,857, issued on Feb. 17, was assigned to Cytiva Bioprocess R&D AB (Uppsala, Sweden).

"Method for separation of antibodies or antibody fragments being devoid of an Fc region capable of binding to protein A" was invented by Gustav Rodrigo (Uppsala, Sweden), Mats Ander (Uppsala, Sweden), Tomas Bjorkman (Uppsala, Sweden), Ronnie Palmgren (Uppsala, Sweden) and Charlotte Brink (Uppsala, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention discloses a method for separation of antibodies or antibody fragments, comprising the steps of: a) providing a feed comprising antibodies or antibody fragments having a VH3 region and being devoid of an Fc ...